Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 23Phase NA 16Phase 3 12Phase 1/2 11Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 13Lymphoid 12Other hematologic neoplasm 10CNS 6Gynecologic 2Genitourinary 2Sarcoma 1Other solid neoplasm 1NET 1Gastrointestinal 1Endocrine 1Dermatologic 1Breast 1

Conditions

Breast Neoplasms 182Triple Negative Breast Neoplasms 24Lung Neoplasms 16Ovarian Neoplasms 11Melanoma 11Prostatic Neoplasms 10Pancreatic Neoplasms 10Colonic Neoplasms 10Sarcoma 9Neoplasms 8Stomach Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Head and Neck Neoplasms 6Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Urinary Bladder Neoplasms 5Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Renal Cell 5Breast Neoplasms, Male 5Uterine Cervical Neoplasms 4Glioblastoma 4Carcinoma, Ductal, Breast 4Brain Neoplasms 4Small Cell Lung Carcinoma 3Liver Neoplasms 3Kidney Neoplasms 3Endometrial Neoplasms 3Carcinoma, Lobular 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Recurrence × Breast × Clear all
NCT02646319 2019-06-06

Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

Mayo Clinic

Phase EARLY_PHASE1 Completed
2 enrolled
BreastGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Recurrence, Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡